287 related articles for article (PubMed ID: 18301941)
21. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
[TBL] [Abstract][Full Text] [Related]
22. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders?
Liraud F; Verdoux H
Psychiatry Res; 2000 Feb; 93(1):63-72. PubMed ID: 10699229
[TBL] [Abstract][Full Text] [Related]
23. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
24. The incidence of schizotypy among cannabis and alcohol users.
Nunn JA; Rizza F; Peters ER
J Nerv Ment Dis; 2001 Nov; 189(11):741-8. PubMed ID: 11758656
[TBL] [Abstract][Full Text] [Related]
25. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Conway KP; Compton W; Stinson FS; Grant BF
J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
[TBL] [Abstract][Full Text] [Related]
26. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
[TBL] [Abstract][Full Text] [Related]
27. Development of substance use and psychiatric comorbidity in an epidemiologic study of white and American Indian young adolescents the Great Smoky Mountains Study.
Federman EB; Costello EJ; Angold A; Farmer EM; Erkanli A
Drug Alcohol Depend; 1997 Mar; 44(2-3):69-78. PubMed ID: 9088778
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
29. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
[TBL] [Abstract][Full Text] [Related]
30. Self-mutilation in substance-dependent patients and relationship with childhood abuse and neglect, alexithymia and temperament and character dimensions of personality.
Evren C; Evren B
Drug Alcohol Depend; 2005 Oct; 80(1):15-22. PubMed ID: 16157228
[TBL] [Abstract][Full Text] [Related]
31. Polydrug use in adolescent drinkers with and without DSM-IV alcohol abuse and dependence.
Martin CS; Kaczynski NA; Maisto SA; Tarter RE
Alcohol Clin Exp Res; 1996 Sep; 20(6):1099-1108. PubMed ID: 8892534
[TBL] [Abstract][Full Text] [Related]
32. Rates of DSM-IV psychiatric disorders among adolescents in a large metropolitan area.
Roberts RE; Roberts CR; Xing Y
J Psychiatr Res; 2007 Dec; 41(11):959-67. PubMed ID: 17107689
[TBL] [Abstract][Full Text] [Related]
33. DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.
Livne O; Shmulewitz D; Lev-Ran S; Hasin DS
Drug Alcohol Depend; 2019 Feb; 195():170-177. PubMed ID: 30361043
[TBL] [Abstract][Full Text] [Related]
34. Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health.
Lopez-Quintero C; Granja K; Hawes S; Duperrouzel JC; Pacheco-Colón I; Gonzalez R
Addict Behav; 2018 Oct; 85():43-50. PubMed ID: 29843040
[TBL] [Abstract][Full Text] [Related]
35. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
[TBL] [Abstract][Full Text] [Related]
36. [Relations between anxious, depressive and borderline symptomatology and frequency of cannabis use and dependence].
Chabrol H; Duconge E; Roura C; Casas C
Encephale; 2004; 30(2):141-6. PubMed ID: 15107716
[TBL] [Abstract][Full Text] [Related]
37. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.
Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J
J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428
[TBL] [Abstract][Full Text] [Related]
38. Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.
Butelman ER; Chen CY; Fry RS; Kimani R; Levran O; Ott J; Correa da Rosa J; Kreek MJ
Drug Alcohol Depend; 2018 Sep; 190():179-187. PubMed ID: 30041093
[TBL] [Abstract][Full Text] [Related]
39. Mood disorder, anxiety, and suicide risk among subjects with alcohol abuse and/or dependence: a population-based study.
Wiener CD; Moreira FP; Zago A; Souza LM; Branco JC; Oliveira JF; Silva RAD; Portela LV; Lara DR; Jansen K; Oses JP
Braz J Psychiatry; 2018; 40(1):1-5. PubMed ID: 28658442
[TBL] [Abstract][Full Text] [Related]
40. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
